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ABSTRACT Graft failure and extrahepatic organ complications, which 
frequently develop after transplantation, may be related to inflammatory 
mediators stimulated by endotoxin (ET). The role of endotoxemia after 
liver transplantation is controversial and may depend upon differences in 
the ET assay method used in the various contradicting studies. While the 
standard Limulus amebocyte lysate (LAL) is reactive for ET and tJ-glucan, 
a novel turbidimetric assay method enables separate determinations of 
ET and tJ-glucan. Beagle dogs undergoing orthotopjc liver transplanta-
tion were divided into two groups. In Group I (n = 6) the grafts were 
transplanted immediately and in Group II (n = 6) grafts were preserved 
for 48 h in University of Wisconsin (UW) solution. Animals received 
cyclosporine immunosuppression and were followed for 14 days. Daily 
measurements of aspartate aminotransferase (AST), alanine aminotrans-
ferase (ALT), and lactate dehydrogenase (LDH) were performed. Samples 
for ET and tJ-glucan measurement were collected serially and processed 
using the turbidimetric assay method. While no graft failure was seen in 
Group I, three of six Group II animals died from graft failure within 1 day 
after transplantation. Preservation and reperfusion injury was much more 
severe in the Group II grafts than in Group I grafts. While endotoxemia 
could not be detected, postoperative tJ-glucan levels (undetectable pre-
transplant) were seen in both groups. tJ-Glucan levels were much higher 
in Group II grafts than in Group I grafts, and correlated with the severity 
ofliver damage. In conclusion, this study shows that tJ-glucann, instead 
of ET, appears during the early posttransplant period. We believe that 
posttransplant elevation of ~-glucan is related to liver damage, especially 
endothelial damage by preservation and reperfusion. 
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A lthough orthotopic liver transplantation has become a standard treatment for patients with end-stage liver disease, graft failure 
and extrahepatic organ complications frequently develop after 
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transplantation [1]. These complications may be re-
lated to inflammatory mediators stimulated by endo-
toxin (ET) escaping hepatic filtration. We [2-4] and 
others [5-7] have previously reported postoperative 
endotoxemia, in which ET levels correlated with the 
severity of liver injury and clinical outcome. How-
ever, endotoxemia after liver transplantation was not 
always seen in some studies [8-10]. Differences in 
the ET assay method appear to cause the discrep-
ancy. Previously, we measured ET by a chromogenic 
standard Limulus amebocyte lysate (LAL) assay. The 
standard LAL is not specific foi ET because it is 
also reactive to ,B-glucan [11]. In this study, endo-
toxemia after canine liver transplantation was reex-
amined by a novel turbidimetric assay method that 
enables separate determinations ofET and ,B-glucan. 
METHODS 
This study was approved by the University of 
Pittsburgh's Institutional Animal Care and Use Com-
mittee. Healthy female beagle dogs, weighing 9 to 
11 kg, were used. Orthotopic liver transplantation 
with the use of a vena-venous bypass was performed 
by the method described previously [12]. The animals 
were divided into two experimental groups: Group I 
(n = 6), undergoing immediate liver transplantation, 
and Group II (n = 6), receiving livers that were pre· 
served for 48 h with University of Wisconsin (UW) 
solution (ViaSpan, DuPont, Wilmington. DE). A 
modification of the simple cold storage method [13] 
was used for preservation of Group II livers. After 
in situ flushing with UW solution and occlusion of 
the vena cava and hepatic artery, grafts were flushed 
with an additional 30% of UW solution (1% ac-
counts for 1 mIll g graft weight) through a portal ve-
nous cannulao Animals wereOgiven oral cyclosporine, 
20 mg/kg, from the next morning for posttransplant 
immunosuppression and tollowed ror 14 days. Daily 
measurements of aspartateaminotransferase (ASD, 
alanine aminotransferase (ALD, and lactate dehydro-
genase (LDH) were performed until sacrifice. 
ET and /3-Glucan Measurement 
Before starting the recipient operation, at the end 
of the anhepatic phase (5 min before graft reperfu-
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sian), and at 005, 1, 3, 6, 12, and 24 h after trans-
plantation, 5 ml of the peripheral venous blood was 
drawn in a sterile fashion into a pyrogen-free plastic 
syinge containing 50 IU heparin. The samples were 
transferred immediately into pyrogen-free test tubes, 
placed on ice, and centrifuged at 42 C at 3000 rpm for 
40 s. Th.e separated platelet-rich plasma was stored at 
-80a C. Measurements ofET and ,B-glucan were au-
tomatically performed in duplicate by a kinetic tur-
bidimetric method using ES buffer and HS buffer, 
respectively, and a toxinometer (ET-251, Wako Pure 
Chemical Industries Ltd., Osaka, Japan). The ES 
buffer is an endotoxin-specific LAL reagent with in-
activated glucan factor (G-factor). The HS buffer is 
specific for ,B-glucan and eliminated ET activity from 
the assay. Samples for both assays underwent deter-
gent dilution and heat inactivation prior to measure-
ment. The minimum detection limit was 1.4 pglml 
for ET and 0.19 nglml for ,B-glucan. Results are ex-
pressed as the mean ± SO. One-way analysis of vari-
ance was used to compare group means using the 
software packages Statistica (StatSoft, Tulsa, OK) and 
SPSS (SPSS, Inc., Chicago). 
RESULTS 
Survival, maximum AST, ALT, and LDH values, 
peak ET and ,B-glucan levels, and cause of mortality 
in Group I and Group II animals after liver trans-
plantation are shown in Table 1. In Group I, 2 of 
6 died before 14 days; one died on postoperative 
day (POD) 1 from pulmonary hemorrhage and the 
other was lost to intussusception on PO 06. No graft 
failure was seen in this group. In contrast. 3 of 6 
Group II animals died from graft failure within 1 day 
after transplantation. The remaining 3 survived for 
14 days. Liver enzyme levels indicated that preser-
vation and reperfusion injury was much more severe 
in the Group II grafts than in grafts that underwent 
immediate transplantation. While endotoxemia 
could not be detected in either Group I animals or 
Group II animals at any stage of liver transplant-
ation, postoperative ,B-glucan levels were seen in 
both groups. [,B-Glucan levels, undetectable before 
the operation, increased significantly at the end of 
the anhepatic phase in both groups (Figure 1).] 
After graft reperfusion, ,B-glucan levels of Group I 
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TABLE 1 Results of orthotopic liver transplantation In dogs 
Maximum value Peak levels 
Experiments Survival (days) AST (lUlL) ALT (lUlL) LDH (lUlL) Endotoxin fl-Glucan (nglml) Cause of death 
Group I 
1 6 849 845 570 NO 7.12 Intussusception 
2 14 301 805 496 NO 3.5 Scheduled sacrifice 
3 14 1495 1560 1020 NO 2.2 Scheduled sacrifice 
4 1900 2285 2435 NO 4.53 Hemorrhage lung 
5 14 1090 1130 575 NO 6.17 Scheduled sacrifice 
6 14 1800 568 717 NO 4.15 Scheduled sacrifice 
Group II 
1 14 4960 5160 5260 NO 20.09 Scheduled sacrifice 
2 14 3212 3120 1940 NO 15.29 Scheduled sacrifice 
3 14 5070 6150 2850 NO 10.22 Scheduled sacrifice 
4 1 9000 10,080 3780 NO 20.69 Graft failure 
5 0.5 19,240 18,000 6020 NO 26.47 Graft failure 
6 10,116 6984 3420 NO 24.83 Graft failure 
Note. ND. not detected; AST, aspartate aminotransferase, ALl alanine ammotransferase; LDH, lactate dehydrogenase 
animals peaked at 0.5 to 1 h (mean peak level 
4.6 ± 1.8 ng/ml), and became undetectable after 
6 to 24 h. In Group II, the postreperfusion increase 
of tJ-glucan was enhanced (mean peak level 
19.6 ± 6.0 ng/ml) and lasted for a longer period than 
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in Group I, with peak levels 4 to 5 times higher at 
3 and 6 h after repedusion. tJ-Glucan of the 3 failed 
grafts remained elevated, and tJ-glucan levels of the 
14-day survivors showed some reduction 24 h after 
reperfusion. 
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FIGURE 1 {l-Glucan levels after transplantation for Group I and Group II. R·5 represents 5 min before reperfuslon; +, 
failed grafts. 
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DISCUSSION 
ET causes gelation and clotting of LAL extracted 
from horseshoe crab hemocytes. Since Bevin and 
Bang [14] first found this phenomenon, LAL has 
been used, as a Limulus test, to detect ET in blood 
and pharmaceutical products. However, due to prob-
lems of sensitivity and quantification with the Limu-
Ius test, new ET assay methods, such as chromogenic 
analysis [15], turbidimetry [16], and enzyme-linked 
immunosorbent assay by monoclonal antibody [17], 
have recently been developed. These methods have 
enabled measurement of ET at very low concen-
trations (picogram), and revealed endotoxemia in 
patients with sepsis and liver diseases [15, 16]. How-
ever, when standard LAL was used for measurements, 
it was found that ,B-glucan interfered with the results 
when present in the assay system. Iwanaga et al. {18] 
has reported that the coagulation cascade of standard 
LAL is initiated through either ET-sensitive factor C 
or ,B-glucan-sensitive factor G. Therefore, either the 
modified LAL that eliminates factor G or the modi-
fied assay method that inactivates factor G is neces-
sary to measure ET specifically. 
In our previous study using a chromogenic assay 
with standard LAL, we reported endotoxemia dur-
ing the perioperative period of liver transplantation 
in experimental animals f2l and in patients [3, 4]. 
ET levels correlated with the severity of liver injury, 
primary graft nonfunction, overall graft loss, OKT3 
use, and extrahepatic organ dysfunction. From our 
previous results, we speculated that inflammatory 
mediators stimulated by ET may cause hepatic and 
extrahepatic complications after liver transplantation. 
However, in this study, a turbidimetric analysis 
showed no endotoxemia in any of the experimen-
tal animals even though we used the same oper-
ative procedure and postoperative management as 
in the previous study. The differences in these obser-
vations may be attributed to the ET assay method. 
The standard LAL ET assay is incapable of differen-
tiating between ET and ,B-glucan, while the turbidi-
metric method is specific for endotoxin. The stan-
dard LAL was used in the previous study, because it 
was the only method available at that time to mea-
sure ET; however, a modified LAL assay has provided 
results compatible with the turbidimetric method in 
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experiments testing the recovery rate ofET, as shown 
in our laboratory (unpublished data) and by others 
[ 16]. 
The present study showed the presence of ,B-glu-
can, instead of ET, during the early postoperative 
period. ,B-Glucan was undetectable before the op-
eration, appeared at the anhepatic phase, and el-
evated transiently after reperfusion of the graft in 
both groups. Postoperative elevation of ,B-glucan was 
higher after 48-h liver preservation than with imme-
diate transplantation, and correlated with the sever-
ity of liver damage. 
,B-Glucan is one of the most important constitu-
ents of the cell wall of fungi [19]. It protects fungi 
from deformity, desiccation, and environmental al-
terations. In addition, ,B-glucan-like activity has been 
demonstrated with hemodialyzing membranes made 
of cellulose [20] and in human plasma [21]. As the 
source of ,B-glucan appearing at perioperative ofliver 
transplantation, four possibilities could be consid-
ered: (1) coexistence of fungal infection, (2) impaired 
hepatic filtration or metabolism of ,B-glucan of en-
teric origin, (3) veno-venous bypass system, and (4) 
liberation from the hepatic graft. Fungal infection is 
unlikely because normal healthy animals were sub-
jected to the experiments and no ,B-glucan was de-
tected before operation. ,B-Glucan of enteric orign is 
also unlikely since endotoxin, which is much more 
abundant than ,B-glucan in the enteric lumen, was 
not detected in this study. The veno-venous bypass 
system could, in part, be a source of ,B-glucan because 
similar levels of ,B-glucan were measured in both 
groups during the anhepatic phase. ,B-Glucan-like 
substance was reported to increase also during car-
diopulmonary bypass [7]. However, bypass system 
origin cannot explain the entire profile of ,B-glu-
can in this experiment, in particular marked eleva-
tion of ,B-glucan in Group II after reperfusion. 
Although ,B-glucan levels in portal venous blood 
and hepatic venous blood were not measured, we 
believe that posttransplant elevation of ,B-glucan is 
related to liver damage, especially endothelial dam-
age by preservation and reperfusion. Kikuchi et al. 
[22] found ,B-glucan-like activity in rat organ tissues, 
mostly in vessels. They considered that when vas-
cular damage occurred, ,B-glucan-like substance was 
released from endothelial cells into the circulation. 
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Endothelial cells of the microvasculature have been 
shown to be a main target of preservation and reper-
fusion injury of the liver [23], Whatever the rea-
sons, the results from this study warrant reevaluation 
of endotoxemia in clinical liver transplantation to 
determine the cause of hepatic and extrahepatic com-
plications and to improve their prevention and man-
agement strategy. 
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